The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 30, 2023

Filed:

Nov. 08, 2018
Applicant:

The Scripps Research Institute, La Jolla, CA (US);

Inventor:

Kim D. Janda, La Jolla, CA (US);

Assignee:

The Scripps Research Institute, La Jolla, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 47/64 (2017.01); A61K 47/54 (2017.01); A61K 9/19 (2006.01); A61K 39/39 (2006.01); A61K 47/26 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0013 (2013.01); A61K 9/19 (2013.01); A61K 39/39 (2013.01); A61K 47/26 (2013.01); A61K 47/54 (2017.08); A61K 47/643 (2017.08); A61K 47/646 (2017.08); A61K 47/6415 (2017.08); A61K 2039/55505 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/6081 (2013.01);
Abstract

An improved heroin conjugate vaccine is detailed; to accomplish this task the systematic exploration of twenty vaccine formulations with varying combinations of carrier proteins and adjuvants were undertaken. In regard to adjuvants, a Toll-like receptor 9 (TLR9) agonist and a TLR3 agonist in the presence of alum were explored. The vaccine formulations containing TLR3 or TLR9 agonist alone-elicited strong anti-heroin antibody titers and blockade of heroin-induced antinociception when formulated with alum; however, a combination of TLR3 and 9 adjuvants did not result in improved efficacy. Investigation of stability of the two lead formulations revealed that the TLR9 but not the TLR3 formulation was stable when stored over 30 days. Furthermore, mice immunized with the TLR9+alum heroin vaccine gained significant protection from lethal heroin doses, suggesting that this vaccine formulation is suitable for mitigating the lethal effects of heroin, even following long-term storage at room temperature.


Find Patent Forward Citations

Loading…